| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/06/2010 | EP2139463A2 Anti-infective agents |
| 01/06/2010 | EP2029629B1 Hydrogels of polysaccharide mixtures for tissue engineering and as carriers of active compounds |
| 01/06/2010 | EP1603597B1 Oxycodone conjugates with lower abuse potential and extended duration of action |
| 01/06/2010 | EP1409018B1 Stable lyophilized pharmaceutical formulation the igg antibody daclizumab |
| 01/06/2010 | EP1404360B1 Monodisperse mixtures of calcitonin drug-oligomer conjugates comprising polyethylene glycol, uses thereof, and methods of making same |
| 01/06/2010 | EP1339414B1 L-histidine in ophthalmic solutions |
| 01/06/2010 | CN101618222A Anethol trithione and phospholipid compound and preparation method thereof |
| 01/06/2010 | CN101618221A Preparation method and application of functionalized nano-carbon tube anti-neoplastic drug carrier |
| 01/06/2010 | CN101618220A Anti-tumor predrug by taking novel amphipathic dendritic macromolecules as carriers based on glycerol as branching unit and preparation method thereof |
| 01/06/2010 | CN101618219A Anti-tumor predrug by taking novel amphipathic dendritic macromolecules as carriers based on malic acid as branching unit and preparation method thereof |
| 01/06/2010 | CN101618218A Polyethylene glycol-modified calcitonin |
| 01/06/2010 | CN101618217A Method for coating gastralgia tablets |
| 01/06/2010 | CN100577728C Finely particulate composite containing carbon compound encapsulated therein |
| 01/06/2010 | CN100577685C Long-acting thymosin alpha1 polyethylene glycol modifier |
| 01/06/2010 | CN100577217C Methods of inhibiting the adherence of lenses to their packaging materials |
| 01/06/2010 | CN100577211C Transparent oil-in-water type micro-emulsion stroma and method for preparing the same |
| 01/06/2010 | CN100577210C Drug delivery system based on immune response system |
| 01/06/2010 | CN100577209C Magnetic tumor double-target polymer nano micelle and preparation thereof |
| 01/06/2010 | CN100577208C Technique for preparing embolism agent of granule of polyvinyl formal |
| 01/06/2010 | CN100577207C Active energy radiation hardenable composition for skin plaster and skin plaster |
| 01/06/2010 | CN100577206C Controlled release composition and method of producing the same |
| 01/06/2010 | CN100577203C Use of urease for inhibiting cancer cell growth |
| 01/06/2010 | CN100577191C Ointment for treating bone diseases and its preparing method |
| 01/06/2010 | CN100577178C Soft capsules containing roxithromycin |
| 01/06/2010 | CN100577177C Medical combination of teniposide, the preparing method and use thereof |
| 01/06/2010 | CN100577172C Pharmaceutical compositions for treatment of metabolic bone disease and preparation method thereof |
| 01/06/2010 | CN100577169C Pulse controlled releasing Urapidil tablet and its preparing method |
| 01/06/2010 | CN100577168C Cream for treating alopecia and preparation method thereof |
| 01/06/2010 | CN100577166C Drug formulation having improved oral tolerability |
| 01/06/2010 | CN100577165C Medicinal composition for treating cold wet numbness and preparation method thereof |
| 01/06/2010 | CN100577164C Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 01/06/2010 | CN100577159C Myricetin dispersion tablets for treating cardio-cerebral blood vessel diseases and preparation method thereof |
| 01/06/2010 | CN100577157C Dispersant tablet containing hypolipidemic component and preparation method thereof |
| 01/06/2010 | CN100577156C Instant membrane for paste and preparation method thereof |
| 01/06/2010 | CN100577155C Hard medicine capsule |
| 01/06/2010 | CN100577152C 一种氯沙坦钾氢氯噻嗪片及其制备方法 One kind of losartan potassium and hydrochlorothiazide tablets prepared |
| 01/06/2010 | CN100577150C Abuse-proof dosage form |
| 01/06/2010 | CN100577149C Novel lyophilization protecting agent prescription of A type botulinum toxin freeze-dried powder injection preparation for treatment |
| 01/06/2010 | CN100577037C Alkyldienamides exhibiting taste and sensory effect in flavor compositions |
| 01/05/2010 | US7642343 Micelles; complexes; stability; MALDI-TOF-MS |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642286 Stable pharmaceutical compositions containing pravastatin |
| 01/05/2010 | US7642230 precipitation, freeze drying; for increasing leukocytes; pharmacokinetics |
| 01/05/2010 | US7641917 to make an encapsulated product in particulate form; forming a mixture of a supercritical fluid, a polymeric encapsulating material and an active substance |
| 01/05/2010 | US7641914 Acid-sensitive compounds, their preparation and uses |
| 01/05/2010 | US7641911 Immunological adjuvant compositions |
| 01/05/2010 | US7641905 Methods of inducing an immune response |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641643 Methods and compositions to treat myocardial conditions |
| 01/05/2010 | CA2494045C Film coating for tablets and caplets |
| 01/05/2010 | CA2431690C Hydrocolloid compositions based on ethylene propylene diene monomer polymers |
| 01/05/2010 | CA2425319C Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 01/05/2010 | CA2397546C External plaster |
| 01/05/2010 | CA2358948C Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 01/05/2010 | CA2332642C Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2236023C Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same |
| 12/31/2009 | US20090326633 Controlled release endoprosthetic device |
| 12/31/2009 | US20090326079 Allyl 2-methyl cyclohexane carboxylate; spicy, peppery; woody, fruity; cosmetics; fabrics; cleaning/scrubbing compounds; air fresheners; detergents; dishwashing soaps; window cleaners |
| 12/31/2009 | US20090326078 Process for preparing a solid dosage form |
| 12/31/2009 | US20090326045 Compositions and methods for topical delivery of oligonucleotides |
| 12/31/2009 | US20090325882 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325879 Controlled release copolymer formulation with improved release kinetics |
| 12/31/2009 | US20090325861 Dry wound dressing and drug delivery system |
| 12/31/2009 | US20090325859 Citric acid polymers |
| 12/31/2009 | US20090324863 Sustained-release thermoplastic polymer composition and product comprising the same |
| 12/31/2009 | US20090324742 Peham dendrimers as excipients |
| 12/31/2009 | US20090324741 Injectable polymer-lipid blend |
| 12/31/2009 | US20090324727 Nanoemulsion |
| 12/31/2009 | US20090324716 Coated Particles Containing Pharmaceutically Active Agents |
| 12/31/2009 | US20090324710 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 12/31/2009 | US20090324697 Transdermal hormone delivery system: compositions and methods |
| 12/31/2009 | US20090324692 Polyurethane Elastomers |
| 12/31/2009 | US20090324675 Bioocompatible polymer compositions |
| 12/31/2009 | US20090324663 Kit for formulating a cosmetic product |
| 12/31/2009 | US20090324621 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 12/31/2009 | US20090324620 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 12/31/2009 | US20090324592 Compositions and methods for the diagnosis and treatment of tumor |
| 12/31/2009 | US20090324568 Colonic Delivery of Adsorbents |
| 12/31/2009 | US20090324554 Method for inhibiting or treating a disease associated with intracellular formation of protein fibrillar or aggregates |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/31/2009 | US20090324535 Modified macromolecule |
| 12/31/2009 | US20090324519 Esterification reaction product, gelling agent containing the product, and cosmetic preparation containing them |
| 12/31/2009 | US20090324499 Vitamin-targeted imaging agents |
| 12/31/2009 | US20090324494 Magnetic nano-composite for contrast agent, intelligent contrast agent, drug delivery agent for simultaneous diagnosis and treatment, and separation agent for target substance |
| 12/31/2009 | US20090324492 Treatment for Central Nervous System Disorders |
| 12/31/2009 | US20090324490 Compositions and methods for the diagnosis and treatment of tumor |
| 12/31/2009 | US20090324489 Wortmannin conjugates and uses thereof |
| 12/31/2009 | DE102008040042A1 Microparticle, useful in the diagnosis or therapy of e.g. tumors, metabolic diseases, comprises an aggregate from superparamagnetic nanoparticle, where the nanoparticle exists alone or in combination with an active agent, e.g. antibody |
| 12/30/2009 | WO2009158415A1 Octreotide implant having a release agent |
| 12/30/2009 | WO2009158412A2 Sustained delivery of exenatide and other polypeptides |
| 12/30/2009 | WO2009158256A2 Transdermal delivery apparatus and method |
| 12/30/2009 | WO2009158031A2 Methods and compositions for therapeutic treatment |
| 12/30/2009 | WO2009157596A1 Ophthalmic composition for preventing and treating ocular diseases |
| 12/30/2009 | WO2009157586A1 Transdermal patch containing fentanyl or salt thereof |
| 12/30/2009 | WO2009157564A1 Cellulose composition |
| 12/30/2009 | WO2009157561A1 Polymer/metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same |
| 12/30/2009 | WO2009157558A1 Agent for regenerating tympanic membrane or external auditory canal |
| 12/30/2009 | WO2009157279A1 Liquid composition comprising cisplatin-coordinating compound |